Drugs · acquisition-cost intelligence
Ciprofloxacin and Dexamethasone
ciprofloxacin and dexamethasone· ingredient ciprofloxacinAntiinfectives· CIPROFLOXACIN HYDROCHLORIDE 3 mg/mL; DEXAMETHASONE 1 mg/mL
What this is. Acquisition-cost intelligence for pharmacy & clinic buyers — the historical trend, generic-equivalent costs, and Part D posture. NADAC is a pharmacy acquisition cost (the national average pharmacies pay), not a retail or cash price — for consumer cash prices use GoodRx/your plan.
Acquisition benchmark · NADAC per ML
$7.40
NADAC — pharmacy acquisition cost, not a retail/cash price
Acquisition-cost history
Weekly NADAC per ML — the trend nobody else shows. 7 weeks.
2025-12-172026-05-20
Same-ingredient options by acquisition cost
Other ciprofloxacin products, cheapest acquisition cost first. Per ML — confirm strength/form equivalence before switching.
| Product | NADAC / ML | vs this |
|---|---|---|
| Cipro | $0.11799 | −$7.28 |
| Ciprofloxacin | $0.11799 | −$7.28 |
| Ciprofloxacin HCl Ophthalmic | $1.62 | −$5.78 |
| Ciprofloxacin Otic | $6.85 | −$0.54750 |
| CIPRO HC | $34.87 | +$27.47 |
| CILOXAN | $74.28 | +$66.88 |
Medicare Part D coverage · CY2026
On 277 plan formularies · typical tier 4
Prior auth 0% · Step therapy 0% · Quantity limit 43% of formularies
Sources: CMS NADAC (pharmacy acquisition cost), FDA NDC + RxNorm (identity), RxClass (therapeutic class), CMS Medicare Part D formulary (coverage). Observed reference data for professional buyers — not a retail/cash price, not pricing or medical advice. Verify before purchasing or substituting.